Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The combined treatments were highly effective for improving atrophic acne scars.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Transtherapy significantly improved moderate to severe acne scars without side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.